HAE — HAEMONETICS CORP
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on HAE
| date | signal | measured base rate |
|---|---|---|
| 2026-08-18 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-11 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-07 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-05-28 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-05-14 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-05 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-24 | KROLL MARK W Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | COYLE MICHAEL J Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | Bryant Diane M Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | ABERNATHY ROBERT E Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | Pomeroy Claire Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | Zane Ellen M Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | Madaus Martin D Director | Grant or award | 2.5K | — | — |
| 2026-07-24 | Johnson Lloyd Emerson Director | Grant or award | 2.5K | — | — |
| 2026-06-05 | Miller Laurie A. SVP, Human Resources | Shares withheld for tax | 313 | 71.28 | 22.3K |
| 2026-06-05 | Maunsell Farris Maryanne VP, Chief Accounting Officer | Shares withheld for tax | 259 | 71.28 | 18.5K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 316.7M | 5.6M |
| NEUBERGER BERMAN GROUP LLC | 200.6M | 3.6M |
| AQR CAPITAL MANAGEMENT LLC | 185.7M | 3.4M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 144.2M | 2.6M |
| VANGUARD CAPITAL MANAGEMENT LLC | 117.8M | 2.1M |
| STATE STREET CORP | 99.9M | 1.8M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 77.9M | 1.4M |
| River Road Asset Management, LLC | 74.8M | 1.3M |
| DIMENSIONAL FUND ADVISORS LP | 74.7M | 1.3M |
| FMR LLC | 71.9M | 1.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Ross Stores To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday · 2026-08-21 · benzinga
- Haemonetics stock surges 16% on CSL Plasma supply deal · 2026-08-18
- Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday · 2026-08-18 · benzinga
- Why is Haemonetics stock surging today? · 2026-08-18
- Haemonetics rises after supply deal with CSL · 2026-08-18
- Haemonetics Corp (HAE) filed form 8-K · 2026-08-18 · SEC EDGAR
Ask the AI about HAE
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →